Literature DB >> 27605303

Fractional resurfacing in the Asian patient: Current state of the art.

Heidi Wat1, Douglas C Wu2, Henry Hin Lee Chan3,4.   

Abstract

BACKGROUND AND
OBJECTIVE: Fractionated photothermolysis (FP) has revolutionized modern laser technology. By creating selective columns of microthermal damage, fractionated devices allows for greater treatment depths to be achieved without the prolonged downtime and risk of complications seen in traditional fully ablative laser resurfacing. Fractional resurfacing is a proven method to treat a variety of cutaneous conditions. In the Caucasian patient, a wide range of devices and treatment settings can be utilized safely and effectively. However, ethnic skin requires special consideration due to its unique pigmentary characteristics and clinical presentations. In this review article, we detail the current indications and strategies to optimize results and mitigate complications when utilizing fractional resurfacing for the Asian patient.
METHODS: A review of the MEDLINE English literature was conducted on fractionated laser devices studied in the Asian population. Articles included describe non-ablative devices including fractionated erbium glass, thulium fiber, diode, and radiofrequency devices; and ablative devices including fractionated carbon dioxide (CO2 ) laser, erbium yttrium aluminum garnet and yttrium scandium gallium garnet (YSGG) laser. These data were integrated with the expert opinion of the authors.
CONCLUSION: Taking into account the unique characteristics and cosmetic concerns of the Asian population, fractional resurfacing can be considered a safe and effective option for the treatment of atrophic and hypertrophic scarring, and photorejuvenation in ethnic skin types. Select cases of melasma may be treated with fractionated non-ablative devices, but utilized with caution. The predominant complication associated with fractional resurfacing for these conditions is post-inflammatory hyperpigmentation (PIH) and rebound worsening of melasma. A greater number of treatments at lower density settings and wider treatment intervals typically produce the lowest risks of PIH without compromising treatment efficacy. Lasers Surg. Med. 49:45-59, 2017.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Asian skin; acne scarring; erbium glass; fractional laser; fractional photothermolysis; hypertrophic scarring; melasma; photorejuvenation; resurfacing; thulium fiber

Mesh:

Year:  2016        PMID: 27605303     DOI: 10.1002/lsm.22579

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  5 in total

1.  Treatment of atrophic acne scarring with fractional micro-plasma radio-frequency in Chinese patients: A prospective study.

Authors:  Ting Lan; Yan Xiao; Li Tang; Michael R Hamblin; Rui Yin
Journal:  Lasers Surg Med       Date:  2018-04-16       Impact factor: 4.025

2.  Combination Treatment with Human Adipose Tissue Stem Cell-derived Exosomes and Fractional CO2 Laser for Acne Scars: A 12-week Prospective, Double-blind, Randomized, Split-face Study.

Authors:  Hyuck Hoon Kwon; Steven Hoseong Yang; Joon Lee; Byung Cheol Park; Kui Young Park; Jae Yoon Jung; Youin Bae; Gyeong-Hun Park
Journal:  Acta Derm Venereol       Date:  2020-11-04       Impact factor: 3.875

3.  Fractional CO2 laser and adjunctive therapies in skin of color melasma patients.

Authors:  Carey Kim; Jia C Gao; Janet Moy; Hyun Soo Lee
Journal:  JAAD Int       Date:  2022-07-20

4.  Rapid Wound Healing and Acne Scar Improvement After Ablative Fractional Carbon Dioxide Laser Treatment Combined with the Application of Platelet-Lyophilized Treatment (PLT).

Authors:  Chieh-Chen Huang; Haw-Yueh Thong
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-06-25

5.  Treatment of acne scarring with a novel fractionated, dual-wavelength, picosecond-domain laser incorporating a novel holographic beam-splitter.

Authors:  Eric F Bernstein; Kevin T Schomacker; Lisa D Basilavecchio; Jessica M Plugis; Jayant D Bhawalkar
Journal:  Lasers Surg Med       Date:  2017-09-28       Impact factor: 4.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.